Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.01 and traded as low as $1.06. Predictive Oncology shares last traded at $1.11, with a volume of 324,449 shares trading hands.
Predictive Oncology Trading Down 6.3 %
The business has a 50 day moving average of $1.22 and a 200-day moving average of $2.00. The stock has a market cap of $4.26 million, a PE ratio of -0.28 and a beta of 1.15.
Predictive Oncology (NASDAQ:POAI – Get Free Report) last posted its earnings results on Tuesday, May 14th. The medical instruments supplier reported ($1.04) earnings per share (EPS) for the quarter. Predictive Oncology had a negative net margin of 754.13% and a negative return on equity of 151.51%. The company had revenue of $0.42 million during the quarter.
Institutional Inflows and Outflows
Predictive Oncology Company Profile
Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.
Featured Articles
- Five stocks we like better than Predictive Oncology
- The 3 Best Retail Stocks to Shop for in August
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Breakout Stocks: What They Are and How to Identify Them
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- What to Know About Investing in Penny Stocks
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.